Zorevunersen may offer improvements to quality of life and clinical outcomes for adolescent patients being treated for Dravet syndrome.

Hypertonic saline and mannitol show similar effects on mortality and intracranial pressure control in children with TBI.

GLP-1 receptor agonist-related agonism may prevent addiction phenotypes across all major drug classes according to authors of a recent study.

Maternal diabetes and being born large for gestational age are linked to a significantly higher risk for adult-onset multiple sclerosis in offspring.

Sleep disorders are associated with greater cognitive impairment and poorer instrumental activities of daily living in patients with AD.

What should patients with Parkinson disease understand about anxiety statistics, risk factors, treatment, and management?

OnabotulinumtoxinA shows a consistent safety profile in adults treated for chronic migraine and at least 1 other indication.

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

Experts analyze the unique biomechanical risks for traumatic brain injury in winter sports following high-profile incidents ...

Adolescent cannabis use is associated with an increased risk for new psychiatric disorders during key developmental stages.

FDA expands Juxtapid approval for pediatric patients aged 2 years and older with homozygous familial hypercholesterolemia to reduce plasma LDL-C levels.

Traumatic brain injury is associated with increased all-cause mortality, an association primarily driven by dementia-related death.